These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 22029190

  • 1. Determination of oxygen derived free radicals producer (xanthine oxidase) and scavenger (paraoxonase1) enzymes and lipid parameters in different cancer patients.
    Samra ZQ, Pervaiz S, Shaheen S, Dar N, Athar MA.
    Clin Lab; 2011; 57(9-10):741-7. PubMed ID: 22029190
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome.
    Baskol G, Aygen E, Erdem F, Caniklioğlu A, Narin F, Sahin Y, Kaya T.
    Acta Obstet Gynecol Scand; 2012 Mar; 91(3):326-30. PubMed ID: 22168506
    [Abstract] [Full Text] [Related]

  • 4. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K, Blazícek P, Waczulíková I, Zitnanová I, Duracková Z.
    Acta Biochim Pol; 2006 Mar; 53(4):783-7. PubMed ID: 17106515
    [Abstract] [Full Text] [Related]

  • 5. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
    Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S.
    BMC Cancer; 2007 Mar 15; 7():48. PubMed ID: 17362500
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis.
    Baskol G, Baskol M, Kocer D.
    Clin Biochem; 2007 Jul 15; 40(11):776-80. PubMed ID: 17477913
    [Abstract] [Full Text] [Related]

  • 9. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
    Camuzcuoglu H, Arioz DT, Toy H, Kurt S, Celik H, Erel O.
    Gynecol Oncol; 2009 Mar 15; 112(3):481-5. PubMed ID: 19101714
    [Abstract] [Full Text] [Related]

  • 10. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis.
    Kannampuzha J, Darling PB, Maguire GF, Donnelly S, McFarlane P, Chan CT, Connelly PW.
    Clin Nephrol; 2010 Feb 15; 73(2):131-8. PubMed ID: 20129020
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of paraoxonase activity and lipid profile in lupus patients].
    Kiss E, Seres I, Zsolt K, Tarr T, Csípo I, Szegedi G, Paragh G.
    Orv Hetil; 2005 Nov 20; 146(47):2395-402. PubMed ID: 16398152
    [Abstract] [Full Text] [Related]

  • 12. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S, Aslan M, Horoz M, Gur M, Erel O.
    Clin Biochem; 2007 Mar 20; 40(5-6):287-91. PubMed ID: 17296173
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation.
    Mehdi MM, Rizvi SI.
    Arch Med Res; 2012 Aug 20; 43(6):438-43. PubMed ID: 22959975
    [Abstract] [Full Text] [Related]

  • 15. Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities.
    Karikas GA, Schulpis KH, Bartzeliotou A, Regoutas S, Thanopoulou C, Papaevangelou V, Giannoulia-Karantana A, Papassotiriou I, Fytou-Pallikari A.
    Scand J Clin Lab Invest; 2009 Aug 20; 69(1):31-5. PubMed ID: 19016076
    [Abstract] [Full Text] [Related]

  • 16. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
    Sutherland WH, Manning PJ, de Jong SA, Allum AR, Jones SD, Williams SM.
    Metabolism; 2001 Mar 20; 50(3):319-24. PubMed ID: 11230785
    [Abstract] [Full Text] [Related]

  • 17. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
    Himbergen TM, van Tits LJ, Voorbij HA, de Graaf J, Stalenhoef AF, Roest M.
    J Intern Med; 2005 Nov 20; 258(5):442-9. PubMed ID: 16238680
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.